Minocycline and riluzole brain disposition
Amyotrophic lateral sclerosis is a neurodegenerative fataldisease. The only drug recognized to increase the survivaltime is riluzole(RLZ). In animal models, minocycline (MNC)delayed the onset of the disease and increased the survivaltime (in combination with RLZ). The objective of our workwas to stu...
Saved in:
| Main Author: | Milane, Aline (author) |
|---|---|
| Other Authors: | Fernandez, Christine (author), Vautier, Sarah (author), Meininger, Vincent (author), Farinotti, Robert (author), Bensimon, Gilbert (author) |
| Format: | article |
| Published: |
2007
|
| Online Access: | http://hdl.handle.net/10725/4495 http://dx.doi.org/10.1111/j.1471-4159.2007.04772.x http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2007.04772.x/epdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brain and plasma riluzole pharmacokinetics
by: Milane, Aline
Published: (2016) -
Simple liquid chromatographic determination of minocycline in brain and plasma
by: Milane, A.
Published: (2007) -
Impact des pompes d'efflux (abcb1 et abcg2) de la barrière hémato-encéphalique sur le passage cérébral du riluzole et de la minocycline
by: Milane, Aline
Published: (2009) -
Interactions between riluzole and ABCG2/BCRP transporter
by: Milane, Aline
Published: (2009) -
ABCB1 (P-glycoprotein) and blood-brain barrier
by: Milane, Aline
Published: (2006)